nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A new look at the pathogenesis of Pompe disease
|
Raben, Nina |
|
2008 |
30 |
S3 |
p. S86-S87 2 p. |
artikel |
2 |
Biology of the blood-brain barrier: Implications for the mucopolysaccharidoses
|
Begley, David J. |
|
2008 |
30 |
S3 |
p. S84-S85 2 p. |
artikel |
3 |
Bone metabolism: Implications for Gaucher disease
|
Mariani, Giuliano |
|
2008 |
30 |
S3 |
p. S81-S83 3 p. |
artikel |
4 |
Foreword
|
Germain, Dominique P. |
|
2008 |
30 |
S3 |
p. S75-S76 2 p. |
artikel |
5 |
How are biomarkers defined and validated?
|
Winchester, Bryan |
|
2008 |
30 |
S3 |
p. S88-S89 2 p. |
artikel |
6 |
Newborn screening of lysosomal storage disorders in Austria
|
Bodamer, Olaf A. |
|
2008 |
30 |
S3 |
p. S78- 1 p. |
artikel |
7 |
New developments in biomarkers for lysosomal storage disorders
|
Aerts, Johannes M. |
|
2008 |
30 |
S3 |
p. S92-S93 2 p. |
artikel |
8 |
Poster abstracts
|
|
|
2008 |
30 |
S3 |
p. S95-S126 32 p. |
artikel |
9 |
Screening for pompe disease and fabry disease
|
Hwu, Wuh-Liang |
|
2008 |
30 |
S3 |
p. S77- 1 p. |
artikel |
10 |
The role of current biomarkers in the management of lysosomal storage disorders
|
Maire, Irène |
|
2008 |
30 |
S3 |
p. S90-S91 2 p. |
artikel |
11 |
Use of urinary globotriaosylceramide for fabry disease screening in Canada
|
Auray-Blais, Christiane |
|
2008 |
30 |
S3 |
p. S79-S80 2 p. |
artikel |